Cancer diagnoses tended to arise more in patients who bled on oral anticoagulants (OACs), a Canadian population-based cohort ...

A new study suggests that the benefits of prescribing anticoagulation drugs to certain older people outweigh the potential risks.

Original Research on Real-World Outcomes of Anticoagulation and Corticosteroid in COVID-19,” published in the February 2025 ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

oral vitamin K antagonists remain the cornerstone of anticoagulation for long-term treatment or secondary prevention. Much of the research in optimizing anticoagulant therapy for acute VTE has ...

When an older adult with atrial fibrillation, or Afib, stops taking an anticoagulant, it raises their risk of stroke or heart attack more than risks of bleeding, according to a new report published ...

Promising results show that abelacimab could revolutionize anticoagulation therapy by slashing bleeding risks without compromising stroke protection for patients with atrial fibrillation.

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Karen L. Hassenplug, Pharm.D.; Jill S. Burkiewicz, Pharm.D., BCPS; Terri L. Jackson, Ph.D., B.S.Pharm.; Laura R. Peppers, Pharm.D., BCPS Identifying baseline ...

The benefit of direct oral anticoagulants on stroke risk in patients with prior intracerebral hemorrhage and atrial ...

A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.